BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18253960)

  • 1. Low prevalence and assay discordance of "aspirin resistance" in children.
    Yee DL; Dinu BR; Sun CW; Edwards RM; Justino H; Teruya J; Bray PF; Bomgaars L
    Pediatr Blood Cancer; 2008 Jul; 51(1):86-92. PubMed ID: 18253960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin resistance in patients taking small dose of aspirin].
    Wang CB; Hu DY; Shi XB; Zhu ZY; Zhu JY; Yang JG
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):219-23. PubMed ID: 16647012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of laboratory aspirin resistance in 431 old patients].
    Li X; Fan L; Cao J; Wang Q; Liu L; Hu G; Hu Y; Wang Y; Wu R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):338-42. PubMed ID: 22561563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile and prevalence of aspirin resistance in Indian patients with coronary artery disease.
    Sadiq PA; Puri A; Dixit M; Ghatak A; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2005; 57(6):658-61. PubMed ID: 16521633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
    Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
    J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2).
    Blais N; Pharand C; Lordkipanidzé M; Sia YK; Merhi Y; Diodati JG
    Thromb Haemost; 2009 Aug; 102(2):404-11. PubMed ID: 19652893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes.
    Schmugge M; Speer O; Kroiss S; Knirsch W; Kretschmar O; Rand ML; Albisetti M
    Eur J Pediatr; 2015 Jul; 174(7):933-41. PubMed ID: 25589198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
    Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
    Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography.
    Meen O; Brosstad F; Khiabani H; Gjertsen E; Lauritsen ME; Pedersen TM; Bjørnsen S; Schjelderup NM; Ameln W; Ng EC; Wettergreen M; Siddique SP; Erikssen G
    Scand J Clin Lab Invest; 2008; 68(3):185-91. PubMed ID: 17934975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in platelet function testing has a major influence on detection of aspirin resistance in healthy subjects.
    Bozic-Mijovski M; Rakusa M; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):84-90. PubMed ID: 19127088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.